PCV74 INCREMENTAL COSTS OF HYPERTENSION, HYPERGLYCEMIA, HYPERLIPIDEMIA, AND THEIR COMBINATIONS

Autor: RF Pwu, Ca Sun, CH Bai, SL You, CH Tang, ST Hung

Publikováno v: Value in Health. (7):A326

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a694395c026d832b4903e026d3295b5a

The Critical Intersect of Regulations, Health Technology Assessment, and Drug Safety Assessments.

Autor: Yang WW; Data Science Center, Fu Jen Catholic University, No. 510, Zhongzheng Rd., Xinzhuang Dist., New Taipei City, 242062, Taiwan, R.O.C.; Health Outcomes and Technology Teaching and Education Alliance, Taipei City, Taiwan, R.O.C., Juan YC; National Taiwan University Hospital-Integrative Medical Database, Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan, R.O.C., Wu GH; Health Outcomes and Technology Teaching and Education Alliance, Taipei City, Taiwan, R.O.C.; Department of Physical Therapy and Assistive Technology, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C., Pwu RF; Data Science Center, Fu Jen Catholic University, No. 510, Zhongzheng Rd., Xinzhuang Dist., New Taipei City, 242062, Taiwan, R.O.C.. jasminepwu@gmail.com.; Health Outcomes and Technology Teaching and Education Alliance, Taipei City, Taiwan, R.O.C.. jasminepwu@gmail.com.; School of Health Care Administration, Taipei Medical University, Taipei City, Taiwan, R.O.C.. jasminepwu@gmail.com.

Publikováno v: Drug safety [Drug Saf] 2024 Apr; Vol. 47 (4), pp. 289-299. Date of Electronic Publication: 2023 Dec 19.

Managing the transition in cervical screening methods for Taiwan: Policy recommendations and perspectives.

Autor: Chen CC; Department of Pathology, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, 600, Taiwan; Department of Cosmetic Science, Chia Nan University of Pharmacy and Science, Tainan, 717, Taiwan; Ph.D. Program in Translational Medicine, Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, 402, Taiwan; Department of Biotechnology and Bioindustry Sciences, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan, 701, Taiwan., Lai CH; Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, 333, Taiwan; Chang Gung University, Taoyuan, 333, Taiwan., Chang CL; Department of Medicine, MacKay Medical College, New Taipei City, 252 Taiwan; Department of Obstetrics and Gynecology, MacKay Memorial Hospital, Taipei, 104, Taiwan., Cheng WF; Department of Obstetrics and Gynecology, College of Medicine, National Taiwan University, Taipei, 100, Taiwan., Pwu RF; School of Health Care Administration, Taipei Medical University, Taipei, 110, Taiwan; Data Science Center, Fu Jen Catholic University, New Taipei City, 242, Taiwan., Tsai J; Formosa Cancer Foundation, Taipei, 105, Taiwan., Wang PH; Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, 112, Taiwan; National Yang Ming Chiao Tung University, Taipei, 112, Taiwan., Whang-Peng J; Formosa Cancer Foundation, Taipei, 105, Taiwan., Lai GM; Formosa Cancer Foundation, Taipei, 105, Taiwan. Electronic address: gminlai@canceraway.org.tw.

Publikováno v: Journal of the Formosan Medical Association = Taiwan yi zhi [J Formos Med Assoc] 2023 Nov; Vol. 122 (11), pp. 1213-1218. Date of Electronic Publication: 2023 Jul 12.

What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection Into the Past and A Way Forward.

Autor: Kc S; Health Intervention and Technology Assessment Program (HITAP), Ministry of Health, Nonthaburi, Thailand., Lin LW; Saw Swee Hock School of Public Health, National University of Singapore (NUS), Singapore, Singapore., Bayani DBS; Saw Swee Hock School of Public Health, National University of Singapore (NUS), Singapore, Singapore., Zemlyanska Y; Saw Swee Hock School of Public Health, National University of Singapore (NUS), Singapore, Singapore., Adler A; The Oxford Centre for Diabetes, Endocrinology, and Metabolism, University of Oxford, Oxford, UK., Ahn J; Ewha Womans University, Seoul, South Korea., Chan K; Sunnybrook Odette Cancer Centre, Toronto, ON, Canada.; Sunnybrook Research Institute, Toronto, ON, Canada.; Canadian Centre for Applied Research in Cancer Control, Toronto, ON, Canada., Choiphel D; Essential Medicine and Technology Division, Department of Medical Services, Ministry of Health, Thimphu, Bhutan., Genuino-Marfori AJ; Health Technology Assessment Unit, Department of Health, Quezon City, Philippines., Kearney B; Faculty of Medicine, University of Adelaide, Adelaide, SA, Australia.; Health Policy Advisory Committee on Technology, Brisbane, QLD, Australia., Liu Y; China Health Technology Assessment Centre, National Health Development Research Centre, Ministry of Health, Beijing, China., Nakamura R; Hitotsubashi Institute for Advanced Study, Hitotsubashi University, Tokyo, Japan., Pearce F; Agency for Care Effectiveness, Ministry of Health, Singapore, Singapore., Prinja S; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India., Pwu RF; Taiwan National Hepatitis C Program Office, Ministry of Health and Welfare, Taipei, Taiwan., Akmal Shafie A; Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia., Sui B; China Health Technology Assessment Centre, National Health Development Research Centre, Ministry of Health, Beijing, China., Suwantika A; Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia., Tunis S; Center for Medical Technology Policy (CMTP), Baltimore, MD, USA., Wu HM; Taiwan National Hepatitis C Program Office, Ministry of Health and Welfare, Taipei, Taiwan., Zalcberg J; Cancer Research Program, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.; Department of Medical Oncology, Alfred Hospital, Melbourne, VIC, Australia., Zhao K; China Health Technology Assessment Centre, National Health Development Research Centre, Ministry of Health, Beijing, China., Isaranuwatchai W; Health Intervention and Technology Assessment Program (HITAP), Ministry of Health, Nonthaburi, Thailand.; Centre for Excellence in Economic Analysis Research, St. Michael's Hospital, Toronto, ON, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada., Teerawattananon Y; Health Intervention and Technology Assessment Program (HITAP), Ministry of Health, Nonthaburi, Thailand.; Saw Swee Hock School of Public Health, National University of Singapore (NUS), Singapore, Singapore., Wee HL; Saw Swee Hock School of Public Health, National University of Singapore (NUS), Singapore, Singapore.; Department of Pharmacy, Faculty of Science, National University of Singapore (NUS), Singapore, Singapore.

Publikováno v: International journal of health policy and management [Int J Health Policy Manag] 2023; Vol. 12, pp. 6858. Date of Electronic Publication: 2023 Mar 06.

Developing a New Region-Specific Preference-Based Measure in East and Southeast Asia.

Autor: Shiroiwa T; Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Wako, Japan. Electronic address: t.shiroiwa@gmail.com., Murata T; Crecon Medical Assessment Co, Ltd, Tokyo, Japan., Ahn J; Department of Health Convergence, Ewha Womans University, Seoul, Republic of Korea., Li X; China National Health Development Research Center, Beijing, China., Nakamura R; Hitotsubashi Institute for Advanced Study, Hitotsubashi University, Kunitachi, Japan., Teerawattananon Y; Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand; Saw Swee Hock School of Public Health, National University of Singapore, Singapore., Kun Z; China National Health Development Research Center, Beijing, China., Shafie AA; School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia., Valverde H; Institute of Health Policy and Development Studies, University of the Philippines Manila, National Institutes of Health, Manila, Philippines., Lam H; Institute of Health Policy and Development Studies, University of the Philippines Manila, National Institutes of Health, Manila, Philippines., Ng K; Agency for Care Effectiveness, Ministry of Health Singapore, Singapore., Nadjib M; ThinkWell, Jakarta, Indonesia; Department of Health Policy and Administration, University of Indonesia, Depok, Indonesia., Pwu RF; National Hepatitis C Program Office, Ministry of Health and Welfare, Taipei, Taiwan., Nugraha RR; Center for Health Economics and Policy Studies, School of Public Health University of Indonesia, Depok, Indonesia., Chen YC; Master Program of Big Data in Biomedicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan., Fukuda T; Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Wako, Japan.

Publikováno v: Value in health regional issues [Value Health Reg Issues] 2022 Nov; Vol. 32, pp. 62-69. Date of Electronic Publication: 2022 Sep 11.